BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/3/2024 7:21:13 AM | Browse: 35 | Download: 54
 |
Received |
|
2023-12-27 20:42 |
|
Peer-Review Started |
|
2023-12-27 20:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-01-10 19:29 |
|
Revised |
|
2024-02-08 22:20 |
|
Second Decision |
|
2024-03-19 02:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-03-19 07:13 |
|
Articles in Press |
|
2024-03-19 07:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-03-28 02:17 |
|
Publish the Manuscript Online |
|
2024-04-03 07:21 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Editorial |
| Article Title |
Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Katsuhiro Kita and Allen Burdowski |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Katsuhiro Kita, PhD, Assistant Professor, Department of Biology, St. Francis College, 179 Livingston Street, Brooklyn, NY 11201, United States. kkita@sfc.edu |
| Key Words |
Colorectal cancer; Chemotherapy; Microtubule; Combretastatin; Photopharmacology |
| Core Tip |
This review article proposes a potentially new approach to utilize photo-switchable microtubule (MT)-targeting drugs in colorectal cancer (CRC). First, we will start the introduction of CRC and current therapy as well as some updates in 2023. Then, we list a popular MT-targeting drug family, taxanes in CRC. As many readers may be aware, taxanes are not really effective in CRC for some reason. Here, we would like to shed light on optically controllable MT-targeting drugs as potential new drug candidates in CRC management. |
| Publish Date |
2024-04-03 07:21 |
| Citation |
Kita K, Burdowski A. Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management. World J Gastroenterol 2024; 30(13): 1780-1790 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i13/1780.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i13.1780 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
